This compound is a pharmaceutical intermediate used in the synthesis of upadacitinib, a JAK inhibitor. It features a complex polycyclic heteroaromatic system and a benzyl carbamate protecting group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2095311-51-4
4-(4-Chlorobutyl)pyridine hydrochloride
pharmaceutical intermediate for API synthesis
TERT-BUTYL TRANS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE
pharmaceutical intermediate for API synthesis
Tert-butyl N-(azetidin-3-yl)carbamate hydrochloride
pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
MK-1026 Intermediate-Biayrl Ether
pharmaceutical intermediate
4-[(Acetyloxy)methyl]-5-methyl-1,3-dioxol-2-one
pharmaceutical intermediate
4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1H-PYRAZOLE
Pharmaceutical intermediate
3-Methylpyridine-2-carbonitrile
pharmaceutical intermediate
benzyl (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)pyrrolidine-1-carboxylate
WGODLIHFGCQOPO-SJORKVTESA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)OCC5=CC=CC=C5